medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2013, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2013; 29 (2)

Regenerative medicine and its links with sports medicine

Hernández-Hernández A, Anillo-Badias R, Castro-Gutiérrez Y, León-Valdés E, Baganet-Cobas A, Fernández-Delgado N

Language: Spanish
References: 32
Page:
PDF size: 59.38 Kb.


ABSTRACT

The main goal of regenerative medicine is the development of new therapeutic methods useful for the replacement or repair of tissues or to promote its regeneration. These methods have achieved promising results in trauma and orthopedic disorders, mainly with the use of adult stem cells, but also with the use of platelets. The similarity of some of these disorders with those seen by sports doctors in athletes with minor injuries due to their training or sports participation, have allowed these procedures to develop good perspectives in the field of sports medicine, as it was considered that they may also be of great benefit in the treatment of sports injuries. Until recently, the intramuscular use of platelets was completely forbidden by sports authorities who considered this approach another source of doping. However, taking into account that platelet injections for therapeutic purposes do not violate the spirit of sport, in 2011 the prohibition was removed. Currently, the use of stem cells for therapeutic purposes is also not included in the prohibited list of World Anti-Doping Agency. Considering these decisions, an agreement was established between the Institutes of Sports Medicine and Hematology and Immunology, in order to take the first steps to implement these new methods in Sports Medicine.


REFERENCES

  1. Hernández Ramírez P, Dorticós Balea E. Medicina regenerativa: Células madre embrionarias y adultas. Rev Cubana Hematol Inmunol Hemoter [en Internet]. 2004 Dic ; 20(3): Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864 - 02892004000300001&lng=es. (visitado 17/06/2012)

  2. Verfaillie CM , Pera MF , Lansdorp PM. Stem Cells: Hype and reality. Hematology Am Soc Hematol Educ Program.2002:369-91.

  3. Thomson JA , Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al .Embryonic stem cell lines derived from human blastocysts. Science. 1998 Nov 6; 282(5391):1145-7.

  4. Hernández Ramírez P. Medicina regenerativa II: Aplicaciones, realidad y perspectivas de la terapia celular. Rev Cubana Hematol Inmunol Hemoter [en Internet]. 2006 Abr; 22(1): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864 - 02892006000100002&lng=es, [visitado 11/08/ 2012 ]

  5. Parmacek MS, Epstein JA. Pursuing cardiac progenitors: regeneration redux. Cell 2005;120:295-8.

  6. Körbling M, Estrov Z. Adult stem cells for tissue repair. A new therapeutic concept? N Engl J Med 2003 Aug 7; 349 (6):570-82.

  7. Hernández Ramírez P. Medicina regenerativa y células madre. Mecanismos de acción de las células madre adultas. Rev Cubana Hematol Inmunol Hemoter [en Internet]. 2009 Abr; 25(1): Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864 - 02892009000100002&lng=es. [visitado 11/08/2012 ]

  8. Corsi KA, Schwarz EM, Mooney DJ, Huard JJ.Regenerative medicine in orthopaedic surgery. Orthop Res 2007 Oct; 25(10):1261-8.

  9. Moran CJ, Barry FP, Maher SA, Shannon FJ, Rodeo SA. Advancing regenerative surgery in orthopaedic sports medicine: the critical role of the surgeon. Am J Sports Med.2012 Apr; 40(4):934-44.

  10. Khan W S., Johnson D S., Hardingham DS. «The potential use of stem cells for knee articular cartilage repair,»Knee, 2010 Dec; 17 (6) 36974.

  11. Jaiswal P K. Wong K, Khan W S. Operative treatment of knee cartilage injuries: a review of the current literature on non-cell-based and cell-based therapies. Brit J Med Medic Res. 2011; 1(4); S16S37.

  12. Alwattar BJ, Schwarzkopf R, Kirsch T. Stem cells in orthopaedics and fracture healing. Bull NYU Hosp Jt Dis.2011; 69(1):6-10.

  13. Kon E, Filardo G, Di Martino A, Marcacci M.Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc.2011 Apr; 19 (4):516-27.

  14. Bava ED, Barber FA. .Platelet-rich plasma products in sports medicine. Phys Sportsmed. 2011 Sep; 39 (3):94-9.

  15. Mei-Dan O, Lippi G, Sánchez M, Andia I, Maffulli N. Autologous platelet-rich plasma: a revolution in soft tissue sports injury management? Phys Sportsmed.2010 Dec; 38 (4):127-35.

  16. Sah RL, Ratcliffe A. Translational models for musculoskeletal tissue engineering and regenerative medicine. Tissue Eng Part B Rev.2010 Feb; 16(1):1-3.

  17. Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R.2011 Mar; 3 (3):226-50.

  18. Arnoczky SP, Cook JL, Turner AS. Animal models for studying meniscal repair and replacement: what they can and cannot tell us. Tissue Eng Part B Rev. 2010; 16(1):31-39.

  19. Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The role of growth factors in cartilage repair. Clin Orthop Relat Res. 2011; 469:2706-15.

  20. Guercio A, Di Marco P, Casella S, Cannella V, Russotto L, Purpari G, et al . Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Cell Biol Int.2012 Feb 1; 36 (2):189-94.

  21. Torricelli P, Fini M,Filardo G,Tschon M,Pischedda M, Pacorini A, et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop.2011 Oct; 35 (10):1569-76.

  22. Jackson DW. The orthopaedic clinician-scientist. . J Bone Joint Surg.Am. 2001 Jan ; 83(1):131-5.

  23. Khan Y, Yaszemski MJ, Mikos AG, Laurencin CT. Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am. 2008 Feb; 90(Suppl 1):36- 42.

  24. Gulotta LV, Kovacevic D, Packer JD, Deng XH, Rodeo SA. Bone marrow-derived mesenchymal stem cells transduced with scleraxisimprove rotator cuff healing in a rat model. Am J Sports Med.2011 Jun; 39(6):1282-9.

  25. Kovacevic D, Rodeo SA. Biological augmentation of rotator cuff tendon repair. Clin Orthop Relat Res. 2008; 466(3):622-33.

  26. Marcacci M,Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM. Use of platelet-rich plasma for the treatment of refractory jumper's knee. 2010 Aug; 34(6):909-15.

  27. FONT COLOR="#0000ff">Kon E, Filardo G, Delcogliano M, Presti ML, Russo A, Bondi A, et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. 2009 Jun; 40(6):598-603.

  28. WORLD ANTI-DOPING AGENCY. Health, Medical & Research (HMR) Committee Meeting Minutes September 2ND-3rd, 2010. Disponible en: http://www.wada ama.org/Documents/About_WADA/HealthMedicalResearchCommittee_Minutes /WADA_HMR_Committee_Minutes_2010_09.pdf (Visitado 17-08-2012)

  29. Vanguardia. FIFA acepta tratamiento con plaquetas a Humberto Suazo. Disponible en;http://www.vanguardia.com.mx/fifaaceptatratamientoconplaquetasahumbertosuazo -507710.html ( Visitado 10/08/2012)

  30. Notifam. Tratamiento con células madre adultas lleva de regreso al montículo a lanzador de las Grandes Ligas. Disponible en: http://notifam.net/index.php/archives/4997/ (Visitado 10/08/2012)

  31. WORLD ANTI-DOPING AGENCY The 2012 Prohibited List International Standard. Disponible en :http://www.wada-ama.org/Documents/World_Anti- Doping_Program/WADP- Prohibited-list/2012/WADA-Prohibited-List-2012-EN.pdf . ( Visitado 10/08/2012)

  32. WORLD ANTI-DOPING AGENCY The 2013 Prohibited List International Standard. Disponible en :http://www.wada-ama.org/Documents/World_Anti- Doping_Program/WADP -Prohibited-list/2013/WADA-Prohibited-List-2013- EN.pdf (Visitado 10/10/2012)




2020     |     www.medigraphic.com